Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05699629 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Prospective Coronary Heart Disease Cohort

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Eligibility criteria shortened, about 7 wordsv2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
To evaluate the biomarkers for the prognosis of coronary heart disease, patients with coronary heart disease will be recruited and followed up for at least 2 years.
Trial Details
NCT Number NCT05699629
Lead Sponsor Shandong First Medical University
Collaborators: Jinan Central Hospital, Shandong Provincial Hospital, The Second Affiliated Hospital of Shandong First Medical University, Qianfoshan Hospital
Conditions
(from sponsor)		 Coronary Heart Disease, Myocardial Infarction
Related terms Coronary Disease, Myocardial Infarction
Enrollment 50,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov